Cargando…
Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine
The FDA-approved Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is highly effective and essential in preventing acute respiratory diseases (ARDs) in U.S. military recruits. Our study revealed the presence of a previously undetected mutation, not found in the wild-type human adenovirus type 4 (HAdV...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385111/ https://www.ncbi.nlm.nih.gov/pubmed/37514960 http://dx.doi.org/10.3390/vaccines11071144 |
_version_ | 1785081322946953216 |
---|---|
author | Collins, Natalie D. Beaty, Shannon Wallace, Elana Li, Yuanzhang Sanborn, Mark Yang, Yu Adhikari, Anima Shabram, Paul Warfield, Kelly Karasavvas, Nicos Kuschner, Robert A. Hang, Jun |
author_facet | Collins, Natalie D. Beaty, Shannon Wallace, Elana Li, Yuanzhang Sanborn, Mark Yang, Yu Adhikari, Anima Shabram, Paul Warfield, Kelly Karasavvas, Nicos Kuschner, Robert A. Hang, Jun |
author_sort | Collins, Natalie D. |
collection | PubMed |
description | The FDA-approved Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is highly effective and essential in preventing acute respiratory diseases (ARDs) in U.S. military recruits. Our study revealed the presence of a previously undetected mutation, not found in the wild-type human adenovirus type 4 (HAdV-4) component of the licensed vaccine, which contains an amino acid substitution (P388T) in the pre-terminal protein (pTP). This study demonstrated that replication of the T388 HAdV-4 vaccine mutant virus is favored over the wild type in WI-38 cells, the cell type utilized in vaccine manufacturing. However, results from serial human stool specimens of vaccine recipients support differential genome replication in the gastrointestinal tract (GI), demonstrated by the steady decline of the percentage of mutant T388 vaccine virus. Since vaccine efficacy depends upon GI replication and the subsequent immune response, the mutation can potentially impact vaccine efficacy. |
format | Online Article Text |
id | pubmed-10385111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103851112023-07-30 Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine Collins, Natalie D. Beaty, Shannon Wallace, Elana Li, Yuanzhang Sanborn, Mark Yang, Yu Adhikari, Anima Shabram, Paul Warfield, Kelly Karasavvas, Nicos Kuschner, Robert A. Hang, Jun Vaccines (Basel) Article The FDA-approved Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is highly effective and essential in preventing acute respiratory diseases (ARDs) in U.S. military recruits. Our study revealed the presence of a previously undetected mutation, not found in the wild-type human adenovirus type 4 (HAdV-4) component of the licensed vaccine, which contains an amino acid substitution (P388T) in the pre-terminal protein (pTP). This study demonstrated that replication of the T388 HAdV-4 vaccine mutant virus is favored over the wild type in WI-38 cells, the cell type utilized in vaccine manufacturing. However, results from serial human stool specimens of vaccine recipients support differential genome replication in the gastrointestinal tract (GI), demonstrated by the steady decline of the percentage of mutant T388 vaccine virus. Since vaccine efficacy depends upon GI replication and the subsequent immune response, the mutation can potentially impact vaccine efficacy. MDPI 2023-06-25 /pmc/articles/PMC10385111/ /pubmed/37514960 http://dx.doi.org/10.3390/vaccines11071144 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Collins, Natalie D. Beaty, Shannon Wallace, Elana Li, Yuanzhang Sanborn, Mark Yang, Yu Adhikari, Anima Shabram, Paul Warfield, Kelly Karasavvas, Nicos Kuschner, Robert A. Hang, Jun Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title | Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title_full | Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title_fullStr | Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title_full_unstemmed | Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title_short | Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine |
title_sort | differential genome replication of a unique single-amino-acid mutation in the adenovirus-4 component of the live oral adenovirus type 4 and type 7 vaccine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385111/ https://www.ncbi.nlm.nih.gov/pubmed/37514960 http://dx.doi.org/10.3390/vaccines11071144 |
work_keys_str_mv | AT collinsnatalied differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT beatyshannon differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT wallaceelana differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT liyuanzhang differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT sanbornmark differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT yangyu differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT adhikarianima differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT shabrampaul differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT warfieldkelly differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT karasavvasnicos differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT kuschnerroberta differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine AT hangjun differentialgenomereplicationofauniquesingleaminoacidmutationintheadenovirus4componentoftheliveoraladenovirustype4andtype7vaccine |